Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review
by
, , , , ,
Francesco Perri
1,*
,
Giuseppina Della Vittoria Scarpati
2, 
Monica Pontone
1,
Maria Luisa Marciano
1,
Alessandro Ottaiano
3,
Marco Cascella
4,
Francesco Sabbatino
5
,
Agostino Guida
6
,
Mariachiara Santorsola
3,
Piera Maiolino
7,
Ernesta Cavalcanti
8,
Giulia Togo
9,
Franco Ionna
10 and
Francesco Caponigro
1 1
Medical and Experimental Head and Neck Oncology Unit, INT IRCSS Foundation G. Pascale, 80131 Naples, Italy
2
Medical Oncology Unit, Hospital Sir Apicella, Pollena Trocchia, 80040 Naples, Italy
3
SSD Innovative Therapies for Abdominal metastases, Abdominal Oncology, INT IRCCS Foundation G. Pascale, 80131 Naples, Italy
4
Unit of Anestesiology and Pain Therapy, INT IRCCS Foundation G. Pascale, 80131 Naples, Italy
5
Oncology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, 84081 Salerno, Italy
6
U.O.C. Odontostomatologia, AORN A. Cardarelli Hospital, 80131 Naples, Italy
7
Pharmacy Unit, INT IRCCS Foundation G. Pascale, 80131 Naples, Italy
8
Laboratory Medicine, INT IRCCS Foundation G. Pascale, 80131 Naples, Italy
9
Maxillofacial Surgery Unit, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy
10
Otolaryngology Unit, INT IRCCS Foundation G. Pascale, 80131 Naples, Italy
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(15), 3560; https://doi.org/10.3390/cancers14153560
Submission received: 18 May 2022
/
Revised: 11 July 2022
/
Accepted: 19 July 2022
/
Published: 22 July 2022
(This article belongs to the Topic The Tumor Microenvironment and Immune Checkpoint: Implications for Current and Emergent Immunotherapies)
Simple Summary
Metabolic reprogramming is a common phenomenon occurring in several solid tumors, among which are head and neck cancers, which allows them to better survive and progress. The main scope of the present work is to integrate the biological mechanisms underlying metabolic reprogramming, which often occurs in cancer cells, with the current therapeutic possibilities in the field of squamous neoplasms of the head and neck. The final goal is to provide a possible therapeutic approach that employs different combinations of chemotherapy, targeted therapy, and immunotherapy on the basis of the biology of the tumor. Counteracting metabolic reprogramming could be an interesting strategy in the near future.
Abstract
Carcinogenesis is a multistep process that consists of the transformation of healthy cells into cancer cells. Such an alteration goes through various stages and is closely linked to random mutations of genes that have a key role in the neoplastic phenotype. During carcinogenesis, cancer cells acquire and exhibit several characteristics including sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, activating invasion and metastasis, and expressing an immune phenotype, which allow them to evade recognition and destruction through cognate immune cells. In addition, cancer cells may acquire the ability to reprogram their metabolism in order to further promote growth, survival, and energy production. This phenomenon, termed metabolic reprogramming, is typical of all solid tumors, including squamous carcinomas of the head and neck (SCCHN). In this review, we analyze the genetic and biological mechanisms underlying metabolic reprogramming of SCCHN, focusing on potential therapeutic strategies that are able to counteract it.
